Sinopharm says may be able to make over 1 billion vaccine doses in 2021

Spread the love

BEIJING (Reuters) – China National Pharmaceutical Group (Sinopharm), one of several Chinese firms developing coronavirus vaccines, said it may have the capacity to produce more than 1 billion doses in 2021, Chairman Liu Jingzhen said at a government press conference on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *